Here is the list of prospective DGNS shareholders
24 Sep 2024 10:56
A number of new investors will become shareholders of PT Diagnos Laboratorium Utama Tbk (DGNS) via a rights issue that will be approved by shareholders next week (2/10).
DGNS schedules rights issue to acquire Asa Ren
18 Apr 2024 10:42
PT Diagnos Laboratorium Utama Tbk (DGNS) will conduct rights issue of a maximum of 921 billion new shares worth IDR 25 per share.
Up 25%, NIKL secures the top gainers spot
15 Mar 2024 10:50
The stock of PT Pelat Timah Nusantara Tbk (NIKL) grew up to 25% until the end of yesterday’s (14/3) session.
After suffering losses, Diagnos to acquire DNA data company Asa Ren
14 Mar 2024 14:02
PT Diagnos Laboratorium Utama Tbk (DGNS) will acquire 97.97% of the shares of Asa Ren Pte. Ltd, an AI-based DNA data company registered in Singapore, with a transaction value estimated at IDR 357.89 billion.
Diagnos Laboratorium reported its first loss since debut
05 Mar 2024 11:35
PT Diagnos Laboratorium Utama Tbk (DGNS), a medical laboratory service provider under PT Bundamedik Tbk (BMHS), booked a loss of IDR 13.65 billion in 2023.
COVID-19 crisis subsides, Diagnos Lab eyes 2023 realistically
19 Jun 2023 11:49
PT Diagnos Laboratorium Utama Tbk (DGNS), a clinical laboratory service provider under Bundamedik Group, is anticipating the decline in its revenue and profit post COVID-19 crisis.
DGNS invests in Asa Ren Pte Ltd
01 Feb 2023 11:26
PT Diagnos Laboratories Utama Tbk (DGNS), the operator of the Diagnos clinic, has invested US$ 300,000 in Asa Ren Pte Ltd Singapore. For information, Asa Ren is a start-up company in the field of bioinformatics.
